Peter Stålberg
Professor vid Institutionen för kirurgiska vetenskaper; Endokrinkirurgi
- Telefon:
- 018-611 00 00
- E-post:
- peter.stalberg@uu.se
- Besöksadress:
- Akademiska sjukhuset, ingång 70, 1 tr
751 85 UPPSALA - Postadress:
- Akademiska sjukhuset, ingång 70, 1 tr
751 85 UPPSALA
- Akademiska meriter:
- MD, PhD, Docent
Mer information visas för dig som medarbetare om du loggar in.
Publikationer
Senaste publikationer
- The evolutionary history of metastatic pancreatic neuroendocrine tumours reveals a therapy driven route to high-grade transformation (2024)
- Surgery for advanced pancreatic neuroendocrine neoplasms (2024)
- Surgery for advanced neuroendocrine tumours of the small bowel (2024)
- Author's Reply (2023)
- Overall Survival in Patients with Stage IV Pan-NET Eligible for Liver Transplantation (2023)
Alla publikationer
Artiklar
- The evolutionary history of metastatic pancreatic neuroendocrine tumours reveals a therapy driven route to high-grade transformation (2024)
- Surgery for advanced pancreatic neuroendocrine neoplasms (2024)
- Surgery for advanced neuroendocrine tumours of the small bowel (2024)
- Author's Reply (2023)
- Overall Survival in Patients with Stage IV Pan-NET Eligible for Liver Transplantation (2023)
- Metastatic small-bowel neuroendocrine tumours (2023)
- Preoperative prophylactic active vitamin D to streamline total thyroidectomy (2022)
- Noninvasive detection of any-stage cancer using free glycosaminoglycans (2022)
- Benefit of Primary Tumor Resection in Stage IV, Grade 1 and 2, Pancreatic Neuroendocrine Tumors (2022)
- Risk of Permanent Hypoparathyroidism After Total Thyroidectomy for Benign Disease (2021)
- EZH2 presents a therapeutic target for neuroendocrine tumors of the small intestine (2021)
- Invited Commentary (2021)
- Long-term outcome after resection and thermal hepatic ablation of pancreatic neuroendocrine tumour liver metastases (2021)
- Adrenalectomy in ectopic Cushing's syndrome (2021)
- MiR-486-3p was downregulated at microRNA profiling of adrenals of multiple endocrine neoplasia type 1 mice, and inhibited human adrenocortical carcinoma cell lines (2021)
- 18F-Radiolabeling and Preliminary Evaluation of a HSP90 ligand (2021)
- Pan-genomic characterization of high-risk pediatric papillary thyroid carcinoma (2021)
- Characterization of Glycosphingolipids in the Human Parathyroid and Thyroid Glands (2021)
- Nordic guidelines 2021 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms (2021)
- Whole genome sequencing of apparently mutation-negative MEN1 patients (2020)
- Whole‐genome sequencing of synchronous thyroid carcinomas identifies aberrant DNA repair in thyroid cancer dedifferentiation (2020)
- PTPRM, a candidate tumor suppressor gene in small intestinal neuroendocrine tumors (2019)
- Applying the use of novel biomarkers for neuroendocrine tumors in the clinic (2019)
- Effect of preoperative injection of superparamagnetic iron oxide particles on rates of sentinel lymph node dissection in women undergoing surgery for ductal carcinoma in situ (SentiNot study) (2019)
- Decrease of 5-hydroxymethylcytosine and TET1 with nuclear exclusion of TET2 in small intestinal neuroendocrine tumors. (2018)
- RNA-Sequencing Analysis of Adrenocortical Carcinoma, Pheochromocytoma and Paraganglioma from a Pan-Cancer Perspective (2018)
- Association of a Prophylactic surgical approach to Stage IV Small Intestinal Neuroendocrine Tumors with Survival. (2018)
- Ex Vivo Activity of Cytotoxic Drugs and Targeted Agents in Small Intestinal Neuroendocrine Tumors (2018)
- Ex vivo activity of cytotoxic drugs and targeted agents in small intestinal neuroendocrine tumors (2018)
- U-CAN (2018)
- Simplifying Logistics and Avoiding the Unnecessary in Patients with Breast Cancer Undergoing Sentinel Node Biopsy. A Prospective Feasibility Trial of the Preoperative Injection of Super Paramagnetic Iron Oxide Nanoparticles (2018)
- Preoperative Ga-68-DOTA-Somatostatin Analog-PET/CT Hybrid Imaging Increases Detection Rate of Intra-abdominal Small Intestinal Neuroendocrine Tumor Lesions (2018)
- Global DNA Methylation Analysis Identifies Two Discrete clusters of Pheochromocytoma with Distinct Genomic and Genetic Alterations (2017)
- Detection of Somatic Mutations in Gastroenteropancreatic Neuroendocrine Tumors Using Targeted Deep Sequencing (2017)
- A role for TET2 in parathyroid carcinoma (2017)
- A Role of TETs and 5-Hydroxymethylcytosine in SI-NETs (2017)
- Multiple and Secondary Hormone Secretion in Patients With Metastatic Pancreatic Neuroendocrine Tumors (2017)
- Clinical signs of fibrosis in small intestinal neuroendocrine tumours (2017)
- A MUTYH germline mutation is associated with small intestinal neuroendocrine tumors (2017)
- DcR3, TFF3 and Midkine are Novel Serum Biomarkers in Small Intestinal Neuroendocrine Tumors (2017)
- Superparamagnetic iron oxide nanoparticles as the sole method for sentinel node biopsy detection in patients with breast cancer (2017)
- 5-Hydroxymethylcytosine discriminates between parathyroid adenoma and carcinoma (2016)
- Multiple and Secondary Hormone Secretion in Patients With Metastatic Pancreatic Neuroendocrine Tumours (2016)
- Midkine Is a New Novel Serum Biomarker in Small Intestinal Neuroendocrine Tumors (SI-NETs) (2016)
- A plausible role for actin gamma smooth muscle 2 (ACTG2) in small intestinal neuroendocrine tumorigenesis (2016)
- Long-Term Surveillance of Treated Hyperparathyroidism for Multiple Endocrine Neoplasia Type 1 (2016)
- Endurtekin krampaköst hjá ungri konu (2016)
- An Integrative Genomic Analysis of Formalin Fixed Paraffin-Embedded Archived Serous Ovarian Carcinoma Comparing Long-term and Short-term Survivors (2016)
- Genetics and epigenetics in small intestinal neuroendocrine tumours (2016)
- Activating mutations in CTNNB1 in aldosterone producing adenomas (2016)
- Neomorphic effects of recurrent somatic mutations in Yin Yang 1 in insulin-producing adenomas (2015)
- Spatiotemporal Heterogeneity Characterizes the Genetic Landscape of Pheochromocytoma and Defines Early Events in Tumorigenesis. (2015)
- Somatic Mutations and Genetic Heterogeneity at the CDKN1B Locus in Small Intestinal Neuroendocrine Tumors (2015)
- A review on management discussions of small intestinal neuroendocrine tumors 'midgut carcinoids' (2015)
- Novel somatic mutations and distinct molecular signature in aldosterone-producing adenomas. (2015)
- Left-shifted relation between calcium and parathyroid hormone in Graves' Disease (2014)
- MAX mutations status in Swedish patients with pheochromocytoma and paraganglioma tumours (2014)
- Integrative Genetic Characterization and Phenotype Correlations in Pheochromocytoma and Paraganglioma Tumours (2014)
- Targeted Next Generation Sequencing in the Screening for Familial Neuroendocrine Tumor Syndromes (2014)
- Global DNA methylation patterns in small intestinal neuroendocrine tumors (SI-NETs) (2014)
- TCEB3C a putative tumor suppressor gene of small intestine neuroendocrine tumors (2014)
- ACTG2 Inhibits Growth and Is Epigenetically Repressed in Small Intestinal Neuroendocrine Tumors (2014)
- Recurrent activating mutation in PRKACA in cortisol-producing adrenal tumors (2014)
- Indication for Liver Transplantation in Young Patients with Small Intestinal NETs Is Rare? (2014)
- Peritoneal carcinomatosis from small intestinal neuroendocrine tumors (2014)
- The histone methyltransferase EZH2, an oncogene common to benign and malignant parathyroid tumors (2014)
- Metastases from Neuroendocrine Tumors to the Breast Are More Common than Previously Thought. A Diagnostic Pitfall? (2013)
- Next-generation sequencing in the clinical genetic screening of patients with pheochromocytoma and paraganglioma (2013)
- Somatic Mutations in H-RAS in Sporadic Pheochromocytoma and Paraganglioma Identified by Exome Sequencing (2013)
- TCEB3C (Elongin A3) on chromosome 18 presents a putative tumor suppressor gene of small intestine neuroendocrine tumors. (2013)
- Outcome after resection and radiofrequency ablation of liver metastases from small intestinal neuroendocrine tumours (2013)
- Management of Grave's Disease Is Improved by Total Thyroidectomy (2012)
- Prognostic Relevance of Survivin in Pancreatic Endocrine Tumors (2012)
- Accelerated Proliferation and Differential Global Gene Expression in Pancreatic Islets of Five-Week-Old Heterozygous Men1 Mice (2012)
- 11C-5-hydroxytryptophan positron emission tomography after radiofrequency ablation of neuroendocrine tumor liver metastases (2012)
- Long-Term Results of Surgery for Small Intestinal Neuroendocrine Tumors at a Tertiary Referral Center (2012)
- Surgical management of pancreatico-duodenal tumors in multiple endocrine neoplasia syndrome type 1 (2012)
- Comprehensive Re-Sequencing of Adrenal Aldosterone Producing Lesions Reveal Three Somatic Mutations near the KCNJ5 Potassium Channel Selectivity Filter (2012)
- Different gene expression profiles in metastasizing midgut carcinoid tumors (2011)
- Stenting of the superior mesenteric vein in midgut carcinoid disease with large mesenteric masses (2010)
- MicroRNA profiling of benign and malignant pheochromocytomas identifies novel diagnostic and therapeutic targets (2010)
- Prophylactic Cholecystectomy in Midgut Carcinoid Patients (2010)
- Neurogenin 3 and neurogenic differentiation 1 are retained in the cytoplasm of multiple endocrine neoplasia type 1 islet and pancreatic endocrine tumor cells (2009)
- Differentially regulated genes in MEN1-transfected BON cells using RT-differential display and oligonucleotide microarrays (2009)
- Familial parathyroid tumors (2009)
- The glucocorticoid receptor is overexpressed in malignant adrenocortical tumors (2009)
- Surgical Management of MEN-1 and -2 (2009)
- Surgery and radiofrequency ablation for treatment of liver metastases from midgut and foregut carcinoids and endocrine pancreatic tumors (2008)
- High success rate of parathyroid reoperation may be achieved with improved localization diagnosis (2008)
- Lack of Nuclear Expression of Hairy and Enhancer of Split-1 (HES1) in Pancreatic Endocrine Tumors (2008)
- E-mail access and improved communication between patient and surgeon (2008)
- Surgical treatment of Graves' disease (2008)
- A randomized controlled trial of minimally invasive thyroidectomy using the lateral direct approach versus conventional hemithyroidectomy (2008)
- Co-expression of ghrelin and its receptor in pancreatic endocrine tumours (2007)
- Surgery versus radioiodine therapy as definitive management for Graves' disease: The role of patient preference (2007)
- Minimally invasive thyroid surgery for diagnostic excision of solitary thyroid nodules (2007)
- Nerve stimulation in thyroid surgery (2007)
- Minimally invasive parathyroidectomy using the lateral focused mini-incision technique without intraoperative parathyroid hormone monitoring (2007)
- Recurrence after total thyroidectomy for benign multinodular goiter (2007)
- Minimally invasive parathyroidectomy and thyroidectomy (2007)
- Cervical thymectomy for intrathymic parathyroid adenomas during minimally invasive parathyroidectomy (2007)
- Gastrointestinal stromal tumors express the orexigen ghrelin (2006)
- Intraoperative parathyroid hormone measurement during minimally invasive parathyroidectomy (2006)
- Recognizing genes differentially regulated in vitro by the multiple endocrine neoplasia type 1 (MEN1) gene, using RNA interference and oligonucleotide microarrays (2006)
- Prophylactic level six lymphadenectomy reduces postoperative thyroglobulin levels in papillary thyroid cancer (2006)
- Transfection of the multiple endocrine neoplastia type 1 gene to a human endocrine pancreatic tumor cell line inhibits cell growth and affects expression of junD, delta-like protein 1/preadipocyte factor-1, proliferating cell nuclear antigen and QM/Jif-1 (2004)
- In Situ RNA-RNA Hybridization of Phospholipase C β3 Shows Lack of Expression in Neuroendocrine Tumours (2003)
- Differentially expressed cDNAs in PLCbeta3-induced tumor suppression in a human endocrine pancreatic tumor cell line (2001)
- Subcellular distribution of phospholipase C isoforms in rodent pancreas and gastric mucosa (2000)
- Suppression of the neoplastic phenotype by transfection of phospholipase C3 to neuroendocrine tumor cells (1999)
- Targeted disruption of the mouse PLC b3 gene results in defective preimplantation and tumor predisposition (1998)
- Potential prognostic markers and candidate genetic drivers in small intestine neuroendocrine tumours
- Quantitative Protein Profiling of Adrenal Glands in a Men1 Mouse Model
- Ex vivo activity of cytotoxic drugs and targeted agents in Small Intestinal NETs
- Novel Serum Biomarkers in Small Intestinal Neuroendocrine Tumors
- TFF3 in primary tumours has a negative impact on survival in small intestinal neuroendocrine tumours
- MicroRNA Expression Profiling in adrenals of Multiple Endocrine Neoplasia type 1 Mice
- Outcome after surgery and radiofrequency ablation of liver metastases in small intestinal neuroendocrine tumors
Kapitel
- Multiple Endocrine Neoplasia type 2 (2018)
- Tunntarmen (2017)
- Appendix (2017)
- Therapy for Locoregional Disease (2017)
- Multiple Endocrine Neoplasia (2017)
- Natural History of untreated primary hyperparathyroidism (2016)
- Resection of Small intestinal neuroendocrine tumors (2016)
- Gastrointestinal Neuroendocrine Tumor (NET) Surgery (2014)
- Surgery for primary aldosteronism (2014)
- Neuroendokrina tumörer i gastrointestinalkanalen (2013)
- Gastrointestinal stromacellstumör (GIST) (2013)
- Surgical Management of Multiglandular Parathyroid Disease (2013)
- Remedial Parathyroid Surgery (2012)
- Carcinoid: Presentation and diagnosis surgical managment (2009)
- Surgical managment of MEN 1 and MEN 2 (2009)
Konferenser
